Search

Jacqueline C Bussolari

from Skillman, NJ
Age ~60
Get Report
Also known as:
Jacquelin C Bussolari, Jacqueline C Tortolani
Phone and address:
50 Durham Rd, Montgomery, NJ 08558
(908) 240-2361
Related to:
Christopher Busslar, 29
Connected to:
Andrew J Bussom, 61Scott W Busson, 54Christina Bussone, 27Mark A Bussone, 52Peter J Bussone, 105Dennis D Bussow, 65Shaul Y Bussu, 35Alex Bust, 71Paul R Busta, 70Maria P Bustabad, 63

Jacqueline Bussolari Phones & Addresses

  • 50 Durham Rd, Skillman, NJ 08558 (908) 240-2361
  • Feeding Hills, MA
  • Princeton, NJ
  • Waterford, CT
  • Hillsborough, NJ
  • Manville, NJ
  • 50 Durham Rd, Skillman, NJ 08558

Work

Company: The janssen pharmaceutical companies of johnson & johnson 2000 Position: Senior director, development team leader at janssen pharmaceuticals r and d

Education

School / High School: University of Rochester

Skills

Oncology • Drug Discovery • Drug Development • Clinical Trials • Biotechnology • Clinical Development • R&D • Clinical Research • Gcp • Pharmacology • Fda • Regulatory Affairs • Pharmacovigilance • Validation • Lifesciences • Hematology • Edc • Computer System Validation • 21 Cfr Part 11

Emails

j***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Jacqueline Bussolari Photo 1

Senior Director, Development Team Leader At Janssen Pharmaceuticals R And D

View page
Location:
50 Durham Rd, Skillman, NJ 08558
Industry:
Pharmaceuticals
Work:
The Janssen Pharmaceutical Companies of Johnson & Johnson
Senior Director, Development Team Leader at Janssen Pharmaceuticals R and D
Johnson & Johnson 1993 - 1999
Onocology Discovery Research
Pfizer 1991 - 1993
Research Fellow
Education:
University of Rochester
Skills:
Oncology
Drug Discovery
Drug Development
Clinical Trials
Biotechnology
Clinical Development
R&D
Clinical Research
Gcp
Pharmacology
Fda
Regulatory Affairs
Pharmacovigilance
Validation
Lifesciences
Hematology
Edc
Computer System Validation
21 Cfr Part 11

Publications

Us Patents

Substituted Amino Acids As Erythropoietin Mimetics

View page
US Patent:
6750369, Jun 15, 2004
Filed:
Aug 10, 2001
Appl. No.:
09/927111
Inventors:
Peter J. Connolly - New Providence NJ
Victor T. Bandurco - Bridgewater NJ
Steven K. Wetter - Flemington NJ
Sigmond Johnson - Three Bridges NJ
Jacqueline Bussolari - Skillman NJ
William V. Murray - Belle Mead NJ
Assignee:
Ortho McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07C22934
US Classification:
562444, 514567
Abstract:
This invention relates to a series of substituted amino acids of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention are small molecules which bind to the erythropoietin receptor and compete with the natural ligand for binding to this receptor.

Combination Therapy Comprising Glucose Reabsorption Inhibitors And Retinoid-X Receptor Modulators

View page
US Patent:
6838442, Jan 4, 2005
Filed:
Apr 3, 2002
Appl. No.:
10/115725
Inventors:
Jacqueline C. Bussolari - Skillman NJ, US
Xiaoli Chen - Belle Mead NJ, US
Bruce R. Conway - Doylestown PA, US
Keith T. Demarest - Flemington NJ, US
Hamish N. M. Ross - Far Hills NJ, US
Rafael Severino - Madrid, ES
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 3170
A61K 3828
US Classification:
514 25, 514 3, 514365, 514369, 514451, 514457, 514866
Abstract:
Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Substituted Amino Acids As Erythropoietin Mimetics

View page
US Patent:
7153869, Dec 26, 2006
Filed:
Mar 12, 2004
Appl. No.:
10/799324
Inventors:
Peter J. Connolly - New Providence NJ, US
Victor T. Bandurco - Bridgewater NJ, US
Steven K. Wetter - Flemington NJ, US
Sigmond Johnson - Flemington NJ, US
Jacqueline Bussolari - Skillman NJ, US
William V. Murray - Belle Mead NJ, US
International Classification:
A61K 31/445
A61K 31/44
A61K 31/34
A01N 43/26
A01N 43/08
US Classification:
514330, 514354, 514355, 514444, 514471, 514533, 514535, 514539, 514562, 514563, 514567, 514620, 549487, 549 77, 560 39, 560 12, 560 13, 560 42, 562444, 562448, 562430, 562435, 564157, 546225, 546316, 546323
Abstract:
This invention relates to a series of substitituted amino acids of Formula I.

Substituted Amino Acids As Erythropoietin Mimetics

View page
US Patent:
7384979, Jun 10, 2008
Filed:
May 30, 2006
Appl. No.:
11/442920
Inventors:
Peter J. Connolly - New Providence NJ, US
William V. Murray - Belle Mead NJ, US
Steven K. Wetter - Flemington NJ, US
Sigmond Johnson - Flemington NJ, US
Victor T. Bandurco - Bridgewater NJ, US
Jacqueline Bussolari - Skillman NJ, US
Assignee:
Ortho McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/235
A61K 31/24
A61K 31/195
A61K 31/40
US Classification:
514533, 514419, 514538, 514542, 514562, 514563, 514564, 514566
Abstract:
This invention relates to a series of substitituted amino acids of Formula I.

Combination Therapy Comprising Glucose Reabsorption Inhibitors And Retinoid-X Receptor Modulators

View page
US Patent:
8183213, May 22, 2012
Filed:
Oct 24, 2007
Appl. No.:
11/923187
Inventors:
Jacqueline C. Bussolari - Skillman NJ, US
Xiaoli Chen - Belle Mead NJ, US
Bruce R. Conway - Doylestown PA, US
Keith T. Demarest - Flemington NJ, US
Hamish N. M. Ross - Far Hills NJ, US
Rafael Severino - Madrid, ES
Assignee:
Ortho McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/70
A61K 31/425
A61K 31/35
A61K 31/335
US Classification:
514 25, 514365, 514369, 514451, 514452, 514866
Abstract:
Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Combination Therapy Comprising Glucose Reabsorption Inhibitors And Ppar Modulators

View page
US Patent:
8278268, Oct 2, 2012
Filed:
Oct 24, 2007
Appl. No.:
11/923120
Inventors:
Jacqueline C. Bussolari - Skillman NJ, US
Xiaoli Chen - Belle Mead NJ, US
Bruce R. Conway - Doylestown PA, US
Keith T. Demarest - Flemington NJ, US
Hamish N. M. Ross - Far Hills NJ, US
Rafael Severino - Madrid, ES
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 38/28
A61K 38/00
A61K 31/70
A61K 31/44
A61K 31/425
A61K 31/42
A61K 31/215
A61K 31/19
US Classification:
514 59, 514 67, 514 27, 514342, 514369, 514374, 514529, 514569
Abstract:
Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Combination Therapy Comprising Glucose Reabsorption Inhibitors And Ppar Modulators

View page
US Patent:
20030045553, Mar 6, 2003
Filed:
Apr 3, 2002
Appl. No.:
10/115827
Inventors:
Jacqueline Bussolari - Skillman NJ, US
Xiaoli Chen - Belle Mead NJ, US
Bruce Conway - Doylestown PA, US
Keith Demarest - Flemington NJ, US
Hamish Ross - Far Hills NJ, US
Rafael Severino - Madrid, ES
International Classification:
A61K031/4439
A61K031/426
US Classification:
514/340000, 514/369000
Abstract:
Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Combination Therapy Comprising Glucose Reabsorption Inhibitors And Retinoid-X Receptor Modulators

View page
US Patent:
20030195235, Oct 16, 2003
Filed:
Feb 24, 2003
Appl. No.:
10/372517
Inventors:
Jacqueline Bussolari - Skillman NJ, US
Xiaoli Chen - Belle Mead NJ, US
Bruce Conway - Doylestown PA, US
Keith Demarest - Flemington NJ, US
Hamish Ross - Far Hills NJ, US
Rafael Severino - Madrid, ES
International Classification:
A61K031/4439
A61K031/426
A61K031/42
A61K031/4162
A61K031/203
US Classification:
514/340000, 514/559000, 514/341000, 514/369000, 514/389000, 514/378000
Abstract:
Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
Control profile
Jacqueline C Bussolari from Skillman, NJ, age ~60 Get Report